Innovations In Clinical Neuroscience

SEP-OCT 2014

A peer-reviewed, evidence-based journal for clinicians in the field of neuroscience

Issue link: http://innovationscns.epubxp.com/i/425963

Contents of this Issue

Navigation

Page 200 of 201

[ V O L U M E 1 1 , N U M B E R 9 – 1 0 , S E P T E M B E R – O C T O B E R 2 0 1 4 ] Innovations in CLINICAL NEUROSCIENCE 201 201 201 201 201 201 201 201 201 S ubmission requirements for Innovations in Clinical N euroscience (Online ISSN 2158-8341, Print ISSN 2158- 8333) are in accordance with the International Committee of Medical Journal Editors (ICMJE). See U niform Requirements for Manuscripts Submitted to B iomedical Journals. EDITORIAL PURPOSE Innovations in Clinical Neuroscience is a peer- r eviewed electronic-only journal ( www.innovationscns.com) designed to provide healthcare clinicians with up-to-date, evidence-based information on the latest treatment options, new techniques, and practice management issues in the field of neuroscience, including psychiatry, neurology, pain, Alzheimer's, and dementia to improve their daily practice. The journal provides practical information in electronic format on a broad range of pertinent topics that is based on the latest research and is presented in a straightforward "how-to" fashion. SCOPE OF MANUSCRIPTS Manuscripts that meet our editorial purpose include but are not limited to: (1) reports of preclinical and clinical research studies that expand existing knowledge; (2) case studies and reports that stimulate research and the exchange of information; (3) in- depth reviews of clinical practice, management, reimbursement, education, ethics, and legal issues; (4) reviews and reports of contemporary topics in neuroscience that may affect the delivery, reimbursement, or practice of psychiatry, neurology, or related fields of neuroscience. Original Research. Reports of investigations that address questions about clinical care or expand existing knowledge. References and illustrative material are recommended. Must include abstract. Recommended length: up to 6000 words, not including references. Review Articles. Comprehensive articles summarizing basic strategies to facilitate the clinician's approach to diagnosis and treatment and articles highlighting emerging diagnostic and therapeutic modalities. May also include in-depth reviews of clinical practice, management, reimbursement, educational, ethical, and legal issues. At least 25 c urrent references are recommended. Illustrative m aterial is preferred. Must include abstract. Recommended length: up to 6000 words, not including references. C ase Reports. Short presentations of actual cases t hat stimulate research and the exchange of information and illustrate the signs and symptoms, diagnosis, and treatment of a disorder. At least 15 c urrent references are recommended. Illustrative m aterial is preferred. Must include abstract. Recommended length 1000 to 3000 words, not including references. Brief Reports. Short reports of original studies or evaluations or unique, first-time reports of clinical case series. Must include abstract. Recommended length: 1000 to 1500 words (not including references). Commentaries. Essays that address important topics in psychiatric medicine and generally are not linked to a specific article. Commentaries should be well focused, scholarly, and clearly presented. Include approximately 20 references. Recommended length: 1500 to 2000 words. Letters to the Editor. Opinions on cases or articles published in Innovations in Clinical Neuroscience, opinions on other current topics, or short reports of clinical interest. Must be concise and to the point. Please indicate whether the letter is intended for publication. Text should not exceed 600 words, with no more than five references. Letters should be received within two months of the article's publication and may be sent to the original author for reply. The editor reserves the right to edit the material for style, clarity, and size. MANUSCRIPT SUBMISSION Submissions for consideration may be sent electronically to: Elizabeth Klumpp, Executive Editor, eklumpp@matrixmedcom.com. Hard copy submissions are no longer accepted. Cover Letter. Manuscripts should be submitted with a cover letter indicating the article type. The cover letter should give details on any previous or duplicate publication of any of the content and should state that the paper is not under consideration for publication elsewhere. In the cover letter, authors should disclose a ny potential financial conflicts of interest relevant to t he submitted manuscript. For Letters to the Editor, p lease indicate whether the letter is intended for publication. C onflict of Interest Disclosures. All authors s hould disclose any potential financial conflicts of i nterest relevant to the submitted manuscript in the cover letter of the submitted manuscript. A uthor and Copyright Forms. Upon submission, a uthors will be asked to complete and return an Author Form, which requires affiliation information, authorship statement, and financial disclosure. Authors will also be asked to sign and return a copyright form. If the manuscript is accepted and published in Innovations in Clinical Neuroscience, authors must transfer copyright to Matrix Medical Communications. Registration of Clinical Trials. As recommended by the ICMJE, Innovations in Clinical Neuroscience requires as a condition of consideration for publication, registration of all clinical trials in a public trials registry that requires the minimum registration data set as determined by the ICMJE, which can be accessed via http://www.icmje.org/index.html#clin_trials. Please include the trial registry name, registration number, and the url for the registry in the abstract. Inclusion of previously published materials. Any material submitted to Innovations in Clinical Neuroscience that is reproduced from previously published copyrighted material must be accompanied by a letter of permission from the copyright holder. All such material should include a full credit line (e.g., in the figure or table legend) acknowledging the original source. The author is responsible for obtaining the permission and is responsible for any associated fees. MANUSCRIPT PREPARATION Title Page. The title page should contain the following elements: title, author names and institutional affiliations, sources of financial support, name of corresponding author with his or her complete contact information (mailing address, telephone and fax numbers, e-mail address), and word count (text only). Information for Authors

Articles in this issue

Links on this page

Archives of this issue

view archives of Innovations In Clinical Neuroscience - SEP-OCT 2014